Elimination Median systemisk clearance (CL) efter en enkelt intravenøs indgift til patienter med psoriasis lå fra 1, 99 til 2, 34 ml/ dag/ kg. Den mediane halveringstid (t1/ 2) for ustekinumab var ca.
Elimination Median systemic clearance (CL) following a single intravenous administration to patients with psoriasis ranged from 1.99 to 2.34 ml/ day/ kg.